Older adults are assets, but they shouldn’t be commodities.
Academic rigor, journalistic flair
Articles on COVID-19
Displaying 2821 - 2840 of 7952 articles
We tried our hardest to provide the best care in dire circumstances. There wasn’t an alternative.
Understanding numbers in the news or social media can empower you to figure out risks and make good choices. Here’s what to look out for to make sure you aren’t misled by COVID-19 coverage.
Early reports suggested an apparent increase in OCD relapse rates and symptom severity during the pandemic. But a year on, we’re learning this may not be the case.
At a time of pandemic, an extraordinary photographic project unfolded between sheets of clear plastic.
Both Liberal and Labor have had shaky campaigns, but the premier’s gamble that an early poll to capitalise on COVID management is the ticket to another term may well pay off.
Debt relief would improve Caribbean states’ response to global crises.
Provider burnout is expensive for the health system given its associations with low quality of care, absenteeism, and high workforce turnover.
The COVID-19 vaccination programme requires stringent data collection and transparency.
At the current vaccination pace it will take over a decade for South Africa to reach herd immunity, with many lives lost along the way.
England is voting for metro mayors and councils on May 6 at a crucial time for local decision-making.
The followers of QAnon gained national notoriety for their support of former President Donald Trump. But QAnon members are influencing the GOP at the state and local levels, too.
There are many reasons your immune system might react differently to vaccines.
There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination.
Licensing agreements between pharmaceutical companies and the Medicines Patent Pool, in cooperation with the WHO, could accelerate access to doses for the poorest countries.
Twenty years ago, a few small-market Major League Baseball teams used advanced analytics as a secret weapon to compete with large-market teams. But the Moneyball effect is gone now.
The pandemic could be a boon to car use, but it would be a mistake for governments to let that happen. There’s a golden opportunity to push towards a zero-carbon transportation system.
Stories of reaching herd immunity were certainly premature.
The Brazilian president has engineered the conditions for the virus to run rampant through the country while he pursues his own agenda.
The R21 vaccine protected three-quarters of children against malaria in trials.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
